An Australian Berry attacks tumors in five minutes.

The compound obtained from the seed of the Berry, It grows only on the plateau of Atherton, in the State of Queensland, It has been named EBC-46.

After eight years of research at the Institute QIMR Berghofer in Australia, Dr. Glen Boyle has found a Berry that has incredible properties against cancer. The results are derived from experimental treatments with a serum that has been carried out in horses, dogs and cats and much promise for treating tumors and melanoma in face and neck.

Now, a group of scientists will begin clinical testing with the compound obtained from a Berry that grows in the North-East of Australia and is able to remove tumors that appear in the neck and head, as well as melanomas.

The biotechnology company, QBiotics obtained permission to test with this compound discovered by the team led by Glen Boyle, Institute of medical research OIMR Berghoder of the Australian city of Brisbane.

The seed of the berry in question has been synthesized a serum, the EBC-46, to reduce the treatment for a couple of weeks time to a matter of days. The serum is injected into the diseased region and the results can be seen in less of 5 minutes.

The chemical compound has been tested in 300 animals, including horses, cats and dogs, in experiments that demonstrated the effectiveness of 75 per cent and has managed to destroy tumors without any side effects.

“Compound operates primarily in three ways: kills the tumor cells, It cut the blood supply and activates the body's immune system to fix the chaos left (by the tumor)”, explained Boyle.

Five minutes after the first injection, the area becomes a purple, the next day the tumor becomes black and a couple of days later follows; an incredibly rapid evolution. This type of treatment would be, potentially, an accompaniment to the surgery or chemotherapy, not a replacement.

The current problems of the treatment, ignoring that even not have been conducted clinical trials in humans, They lie in the difficulty of obtaining Berry, the application and its uselessness to treat cases of metastatic cancer.

The Berry is, According to Glen, "particularly special to choose where it grows" and treatment is limited to areas where can inject directly. Although these "problems" have not deterred QBiotics, a biotechnology company, to obtain permissions, and funds, to continue with the research.

To prove its effectiveness in human patients could be an excellent choice for the treatment of cancer in patients too weak to face a round of chemotherapy or general anesthesia surgery.

So far it is unknown why Berry produces compound or how it works, but in the near future could be another option to attack cancer and improve the quality of life of patients who suffer from it.

The researchers believe that the pre-clinical tests suggest that the drug may be effective in human patients, Although its use is circunscribiría patients with tumors that can be accessed through an injection and excludes those with metastasis.